Could miglustat be a potential candidate in the treatment of action myoclonus renal failure syndrome?

Erdogan, Seyda; Yalçin Çakmakli, Gül; Elibol, Bülent; Ceylaner, Serdar; Akbostanci, M Cenk

Erdogan, Seyda; Yalçin Çakmakli, Gül; Elibol, Bülent; Ceylaner, Serdar; Akbostanci, M Cenk.

Afiliação

Erdogan S; Department of Neurology, School of Medicine, Ankara University, Ibn-I SinaHospital, 06100, Ankara, Turkey. dr_seyda@yahoo.com.
Yalçin Çakmakli G; Department of Neurology, School of Medicine, Hacettepe University, Ankara, Turkey.
Elibol B; Department of Neurology, School of Medicine, Hacettepe University, Ankara, Turkey.
Ceylaner S; Intergen Genetic Diagnosis, Research and Education Center, Ankara, Turkey.
Akbostanci MC; Department of Neurology, School of Medicine, Ankara University, Ibn-I SinaHospital, 06100, Ankara, Turkey.

Acta Neurol Belg ; 123(6): 2441-2444, 2023 12.

Article em En | MEDLINE | ID: mdl-37119471

Assuntos

Epilepsias Mioclônicas Progressivas; Mioclonia; Humanos; 1-Desoxinojirimicina; Mioclonia/tratamento farmacológico

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Epilepsias Mioclônicas Progressivas / Mioclonia Limite: Humans Idioma: En Revista: Acta Neurol Belg Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Turquia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google